Mild Cognitive Impairment Clinical Trial
Official title:
Cognitive Frailty in Older Adults: Protocol of a Pilot RCT of the Role of Technology in Physical Activity Enhancement
NCT number | NCT04692974 |
Other study ID # | H-20-038 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | December 15, 2020 |
Est. completion date | August 2021 |
This study intends to determine if smart watches and mobile phone application prompts can complement physical activity as a preventive intervention by motivating participants to exercise, so as to improve their physical and cognitive outcomes. The investigators hypothesize that technology will help increase engagement in physical activity for the intervention group relative to the control group and subsequently improve cognitive and physical outcomes.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | August 2021 |
Est. primary completion date | August 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 60 Years to 85 Years |
Eligibility | Inclusion Criteria: - Older adults aged 60 to 85 years Exclusion Criteria: - Engages in vigorous exercises as determined by having more than 0 minutes of vigorous exercise on the International Physical Activity Questionnaire (IPAQ). - Has medical contraindications for exercising, including but not limited to: physical disabilities or heart conditions where the primary doctor disallows exercising at moderate intensity. - Does not own an Android phone which can support at least a version 6.0 Operating System |
Country | Name | City | State |
---|---|---|---|
Singapore | Hannah Senior Activity Center | Singapore |
Lead Sponsor | Collaborator |
---|---|
National University, Singapore | Sengkang General Hospital |
Singapore,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Control variable of sleep quality as measured on the Pittsburgh Sleep Quality Index (PSQI) at 3 and 6 months | Self-reported questionnaire on sleep quality in the last month. Global score ranges from 0-21 with a score of 5 and above indicating poor sleep quality. The higher the score, the poorer the sleep quality. | At 3 months and 6 months | |
Other | Control variable of levels of motivation as measured on the Barriers Self-efficacy Scale at 3 and 6 months | Self-reported questionnaire on levels of motivation specific to exercising. Scores ranges from 0-100. The higher the score, the higher the level of self-efficacy. | At 3 months and 6 months | |
Other | Control variable of depression as measured on the Geriatric Depression Scale at 3 and 6 months | Self-reported screening test for depression. Scores ranges from 0-15 and a higher score reflect more depressive symptoms. | At 3 months and 6 months | |
Other | Control variable of anxiety as measured on the Geriatric Anxiety Inventory at 3 and 6 months | Self-reported screening test for anxiety. Scores ranges from 0-20 and a higher score reflect more anxiety symptoms. | At 3 months and 6 months | |
Primary | Mean Change from Baseline in frailty screening scores on the FRAIL questionnaire at 3 and 6 months | 5 questions on fatigue, resistance, ambulation, illness and loss of weight. It is a simple screening test for frailty. Scores of 0 (non-frail), 1-2 (pre-frail) and 3-5 (frail). | At 3 months and 6 months | |
Primary | Mean Change from Baseline in physical frailty as measured by physical performance tests at 3 months and 6 months | Hand grip strength in kilograms | At 3 months and 6 months | |
Primary | Mean Change from Baseline in physical frailty as measured by physical performance tests at 3 months and 6 months | Gait speed, time taken to walk a specified distance as fast as possible, in seconds | At 3 months and 6 months | |
Primary | Mean Change from Baseline in physical frailty as measured by physical performance tests at 3 months and 6 months | Timed Up and Go (TUG), time taken to stand up from a chair, walk 3 meters, turn around and sit back down, in seconds | At 3 months and 6 months | |
Primary | Mean Change from Baseline in physical frailty as measured by physical performance tests at 3 months and 6 months | Chair Stand Test, time taken to stand up fully 5 times from a chair in seconds | At 3 months and 6 months | |
Primary | Mean Change from Baseline in cognitive scores as measured on the Neurocognitive Assessment test battery at 3 and 6 months | Rey Auditory Verbal Learning Test (RAVLT) assesses verbal learning and memory | At 3 months and 6 months | |
Primary | Mean Change from Baseline in cognitive scores as measured on the Neurocognitive Assessment test battery at 3 and 6 months | Digit Span Forward and Backward (DS) assesses working memory capacity | At 3 months and 6 months | |
Primary | Mean Change from Baseline in cognitive scores as measured on the Neurocognitive Assessment test battery at 3 and 6 months | Colour Trails Test (CTT) assesses visual-spatial skills and attention | At 3 months and 6 months | |
Primary | Mean Change from Baseline in cognitive scores as measured on the Neurocognitive Assessment test battery at 3 and 6 months | Wechsler's Block Design (WBS) assesses visuospatial ability | At 3 months and 6 months | |
Primary | Mean Change from Baseline in cognitive scores as measured on the Neurocognitive Assessment test battery at 3 and 6 months | Semantic Fluency - animals (SFA) assesses semantic memory | At 3 months and 6 months | |
Secondary | Mean Change from Baseline in Steps Taken measured by the smart watch at 3 months and 6 months | Number of steps taken daily | At 3 months and 6 months | |
Secondary | Mean Change from Baseline in moderate exercise measured by the smart watch at 3 months and 6 months | Minutes of moderate exercise in a week | At 3 months and 6 months | |
Secondary | Mean Change from Baseline in levels of physical activity measured by the "International Physical Activity Questionnaire" at 3 months and 6 months | Self-reported minutes and hours of vigorous or moderate exercise | At 3 months and 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04513106 -
Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial
|
N/A | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Active, not recruiting |
NCT03167840 -
Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment
|
N/A | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Not yet recruiting |
NCT05041790 -
A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment
|
Phase 4 | |
Recruiting |
NCT04121156 -
High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT03605381 -
MORbidity PRevalence Estimate In StrokE
|
||
Completed |
NCT02774083 -
Cognitive Training Using Feuerstein Instrumental Enrichment
|
N/A | |
Completed |
NCT01315639 -
New Biomarker for Alzheimer's Disease Diagnostic
|
N/A | |
Enrolling by invitation |
NCT06023446 -
Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
|
||
Completed |
NCT04567745 -
Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers
|
Phase 1 | |
Recruiting |
NCT05579236 -
Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
|
||
Completed |
NCT03583879 -
Using Gait Robotics to Improve Symptoms of Parkinson's Disease
|
N/A | |
Terminated |
NCT02503501 -
Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
|
Phase 2 | |
Not yet recruiting |
NCT03740178 -
Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)
|
Phase 1 | |
Active, not recruiting |
NCT05204940 -
Longitudinal Observational Biomarker Study
|
||
Recruiting |
NCT02663531 -
Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease
|
N/A | |
Recruiting |
NCT06150352 -
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
|
||
Recruiting |
NCT03507192 -
Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia.
|
N/A |